NO942707L - Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner - Google Patents

Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner

Info

Publication number
NO942707L
NO942707L NO942707A NO942707A NO942707L NO 942707 L NO942707 L NO 942707L NO 942707 A NO942707 A NO 942707A NO 942707 A NO942707 A NO 942707A NO 942707 L NO942707 L NO 942707L
Authority
NO
Norway
Prior art keywords
rubella
synthetic peptides
peptides suitable
vaccine
protein
Prior art date
Application number
NO942707A
Other languages
English (en)
Norwegian (no)
Other versions
NO942707D0 (no
Inventor
Pele Chong
Shirley Gillam
Dawei Ou
Aubrey Tingle
Original Assignee
Connaught Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Lab filed Critical Connaught Lab
Publication of NO942707D0 publication Critical patent/NO942707D0/no
Publication of NO942707L publication Critical patent/NO942707L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO942707A 1992-01-20 1994-07-19 Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner NO942707L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929201139A GB9201139D0 (en) 1992-01-20 1992-01-20 Synthetic peptides for a rubella vaccine
PCT/CA1993/000014 WO1993014206A2 (fr) 1992-01-20 1993-01-20 Peptides synthetiques destines a un vaccin contre la rubeole

Publications (2)

Publication Number Publication Date
NO942707D0 NO942707D0 (no) 1994-07-19
NO942707L true NO942707L (no) 1994-09-20

Family

ID=10708876

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942707A NO942707L (no) 1992-01-20 1994-07-19 Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner

Country Status (10)

Country Link
US (1) US6037448A (fr)
EP (1) EP0624198A1 (fr)
JP (1) JPH07503133A (fr)
AU (1) AU662954B2 (fr)
CA (1) CA2128407C (fr)
FI (1) FI943418A (fr)
GB (1) GB9201139D0 (fr)
NO (1) NO942707L (fr)
RU (1) RU94040393A (fr)
WO (1) WO1993014206A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427792A (en) * 1989-08-23 1995-06-27 Biochem Immunosystems, Inc. Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
AU1749597A (en) * 1996-01-19 1997-08-11 Virginia Mason Research Center Allele-specific peptide epitope strategy for vaccine development
CA2238660A1 (fr) * 1998-05-22 1999-11-22 Janet Chantler Sequences des genes du virus de la rubeole associees a l'attenuation
SE9903031D0 (sv) * 1999-08-27 1999-08-27 Eurodiagnostica Ab Peptide mixture and vaccine against a chronic viral infection
AU2002326070A1 (en) * 2001-07-02 2003-01-21 Elan Corporation, Plc Peyers's patch and/or m-celle targeting ligands
PL2173376T3 (pl) 2007-08-02 2015-08-31 Biondvax Pharmaceuticals Ltd Multimeryczne wieloepitopowe szczepionki przeciwko grypie
WO2012114323A1 (fr) 2011-02-22 2012-08-30 Biondvax Pharmaceuticals Ltd. Polypeptides multimères multi-épitopes utilisés dans des vaccins contre la grippe saisonnière et pandémique
WO2015082501A1 (fr) * 2013-12-03 2015-06-11 Virometix Ag Peptides riches en proline protecteurs contre s. pneumoniae
CN107098980A (zh) * 2017-06-28 2017-08-29 潍坊汉唐生物工程有限公司 一种检测风疹病毒抗体的融合蛋白及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0299673A1 (fr) * 1987-07-08 1989-01-18 London Biotechnology Limited Antigène de la glycoprotéine E1 de la rubéole
US5164481A (en) * 1989-08-23 1992-11-17 Iaf Biochem International Inc. Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus

Also Published As

Publication number Publication date
CA2128407A1 (fr) 1993-07-22
RU94040393A (ru) 1996-11-10
US6037448A (en) 2000-03-14
AU662954B2 (en) 1995-09-21
AU3341393A (en) 1993-08-03
JPH07503133A (ja) 1995-04-06
EP0624198A1 (fr) 1994-11-17
CA2128407C (fr) 2002-04-09
GB9201139D0 (en) 1992-03-11
FI943418A (fi) 1994-09-15
WO1993014206A3 (fr) 1993-10-28
WO1993014206A2 (fr) 1993-07-22
NO942707D0 (no) 1994-07-19
FI943418A0 (fi) 1994-07-19

Similar Documents

Publication Publication Date Title
DE3588022T3 (de) Pre-S genkodierte Hepatitis B Peptide und diese enthaltende Immunogene und Vakzine
NO913518L (no) Vaksiner for ikke typebestembar haemophilus influenzae.
DK0587780T3 (da) Smitstof, som forårsager Mystery Swine Disease, vaccinepræparater og diagnostiske sæt
GB2255093A (en) Hiv-1 core protein fragments
NO942707L (no) Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner
DE68925660D1 (de) Peptidfragmente von HIV
DK0661999T3 (da) Vacciner mod felint immundefekt virus (FIV)
ATE162550T1 (de) Ospc-antigen-impfstoffe immunogene zusammensetzung zur vorbeugung und behandlung von lyme-krankheit und rekombinante verfahren zur herstellung von derartige antigene
ATE221786T1 (de) Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus
CA2521038A1 (fr) Polypeptide comprenant un motif d'adhesion cellulaire, un epitope de lymphocyte t et un epitope de lymphocyte b utilise pour induire la production d'anticorps
AU4712993A (en) New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods
BRPI0009746B8 (pt) molécula de veículo contendo plasmídeo pg-pviii compreendendo uma seqúência que codifica uma parte de uma glicoproteína de lissavírus contendo pelo menos o sítio iii da glicoproteína de lissavírus mas não contendo o sítio ii, e, composição imunogênica
Balasa et al. Immunotargeting of thyroglobulin on antigen presenting cells abrogates natural tolerance in the absence of adjuvant
KR950701821A (ko) 피임 백신(contraceptive vaccine)
BR9711809A (pt) Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo
SE9202318D0 (sv) Nya peptider, diagnostiska antigen, anvaendning daerav, vacciner och medikamenter
ES1027961U (es) Soporte publicitario para carritos.